Anti-CHIKV [6A11]
Invented at A*STAR Accelerate Technologies Pte Ltd
- Datasheet
- References (0)
- Inventor Info
Info
Catalogue Number | 153200 |
Applications | IF WB |
Antigen/Gene or Protein Targets | N218 epitope on E2 protein of CHIKV |
Synonyms | Chikungunya virus |
Reactivity | Virus |
Relevance | Chikungunya virus (CHIKV) is known to be transmitted to humans by mosquito vectors, primarily Aedes aegypti and A. albopictus. Symptoms of chikungunya infection generally initiated 4–7 days after the bite of the mosquito vector and usually include high fever, asthenia, chills, headache, diarrhoea, vomiting and rash. CHIKV gained its infamity from the severe outbreak in the Indian Ocean island of La Re’union in 2005-2006, in which 38.2% of the population was infected and 41.5 million people were documented to have experienced hemorrhagic fever manifestations. Since the re-emergence of CHIKV in La Reunion, epidemic outbreaks of CHIKV infection have been reported globally and CHIKV is now considered endemic in 34 countries across Europe, Australia, Asia and Africa. Mouse monoclonal antibodies that are specific to chikungunya virus can be used as a research or diagnostic reagent to detect infection of cells. |
Host | Mouse |
Immunogen | Live chikungunya virus |
Positive Control | Infected BHK cells |
Subclass | IgG2b |
Myeloma Used | Sp2/0-Ag14 |
Research Area | Parasitology, Virology |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference